Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial.
Circulation · 2025-Jun-10 · PMID 40156843
Time to first nonfatal stroke event
Figure 1. Cumulative incidence plots of outcomes for oral semaglutide vs placebo in subgroups with or without SGLT2i use at baseline. A , Time to first occurrence of MACE. B , Time to cardiovascular death. C , Time to first nonfatal myocardial infarction event. D , Time to first nonfatal stroke event. E , Time to all-cause death. The cumulative incidence rate is calculated using the Aalen-Johansen method with noncardiovascular death ( A and B )/all-cause death ( C and D ) as a competing risk. CV indicates cardiovascular; HR, hazard ratio; MACE, major adverse cardiovascular event; MI, myocardial infarction; and SGLT2i, sodium-glucose cotransporter-2 inhibitor
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
| Curve | 序号 | X (norm) | Y (norm) | X (real) | Y (real) | X (pixel) | Y (pixel) |
|---|---|---|---|---|---|---|---|
| 1 | 1 | 0.0000 | 0.0088 | 3.0000 | 72 | 112 | |
| 1 | 2 | 0.7993 | 0.0088 | 3.0000 | 311 | 112 | |
| 1 | 3 | 0.9331 | 0.0088 | 3.0000 | 351 | 112 | |
| 1 | 4 | 0.9365 | 0.0088 | 3.0000 | 352 | 112 | |
| 1 | 5 | 0.9398 | 0.0088 | 3.0000 | 353 | 112 | |
| 1 | 6 | 0.9431 | 0.0088 | 3.0000 | 354 | 112 | |
| 1 | 7 | 0.9465 | 0.0088 | 3.0000 | 355 | 112 | |
| 1 | 8 | 0.9498 | 0.0088 | 3.0000 | 356 | 112 | |
| 1 | 9 | 0.9532 | 0.0088 | 3.0000 | 357 | 112 | |
| 1 | 10 | 0.9565 | 0.0088 | 3.0000 | 358 | 112 | |
| 1 | 11 | 0.9599 | 0.0088 | 3.0000 | 359 | 112 | |
| 1 | 12 | 0.9666 | 0.0088 | 3.0000 | 361 | 112 | |
| 1 | 13 | 0.9699 | 0.0088 | 3.0000 | 362 | 112 | |
| 1 | 14 | 0.9732 | 0.0088 | 3.0000 | 363 | 112 | |
| 1 | 15 | 0.9866 | 0.0088 | 3.0000 | 367 | 112 | |
| 1 | 16 | 0.9900 | 0.0265 | 3.0000 | 368 | 110 | |
| 1 | 17 | 0.9933 | 0.0442 | 3.0000 | 369 | 108 | |
| 1 | 18 | 1.0000 | 0.0442 | 3.0000 | 371 | 108 | |
| 3 | 1 | 0.0000 | 0.7522 | 4.0000 | 72 | 28 | |
| 3 | 2 | 0.0033 | 0.7611 | 4.0000 | 73 | 27 | |
| 3 | 3 | 0.0067 | 0.7611 | 4.0000 | 74 | 27 | |
| 3 | 4 | 0.0100 | 0.7699 | 4.0000 | 75 | 26 | |
| 3 | 5 | 0.0134 | 0.7699 | 4.0000 | 76 | 26 | |
| 3 | 6 | 0.0167 | 0.7699 | 4.0000 | 77 | 26 | |
| 3 | 7 | 0.0201 | 0.7699 | 4.0000 | 78 | 26 | |
| 3 | 8 | 0.0234 | 0.7611 | 4.0000 | 79 | 27 | |
| 4 | 1 | 0.0000 | 0.1416 | 3.2500 | 72 | 97 | |
| 4 | 2 | 0.0702 | 0.1416 | 3.2500 | 93 | 97 | |
| 4 | 3 | 0.0769 | 0.1504 | 3.2812 | 95 | 96 | |
| 4 | 4 | 0.0803 | 0.1593 | 3.3125 | 96 | 95 | |
| 4 | 5 | 0.1271 | 0.1681 | 3.3438 | 110 | 94 | |
| 4 | 6 | 0.1304 | 0.1770 | 3.3750 | 111 | 93 | |
| 4 | 7 | 0.1338 | 0.0442 | 3.0000 | 112 | 108 | |
| 4 | 8 | 0.1371 | 0.0442 | 3.0000 | 113 | 108 | |
| 4 | 9 | 0.7993 | 0.0088 | 3.0000 | 311 | 112 | |
| 4 | 10 | 0.8060 | 0.0088 | 3.0000 | 313 | 112 | |
| 4 | 11 | 0.8094 | 0.0088 | 3.0000 | 314 | 112 | |
| 4 | 12 | 0.8127 | 0.0088 | 3.0000 | 315 | 112 | |
| 4 | 13 | 0.8161 | 0.0088 | 3.0000 | 316 | 112 | |
| 4 | 14 | 0.8194 | 0.0088 | 3.0000 | 317 | 112 | |
| 4 | 15 | 0.8227 | 0.0088 | 3.0000 | 318 | 112 | |
| 4 | 16 | 0.8261 | 0.0088 | 3.0000 | 319 | 112 | |
| 4 | 17 | 0.8294 | 0.0088 | 3.0000 | 320 | 112 | |
| 4 | 18 | 0.9064 | 0.0088 | 3.0000 | 343 | 112 | |
| 4 | 19 | 0.9097 | 0.0088 | 3.0000 | 344 | 112 | |
| 4 | 20 | 0.9130 | 0.0088 | 3.0000 | 345 | 112 | |
| 4 | 21 | 0.9164 | 0.0088 | 3.0000 | 346 | 112 | |
| 4 | 22 | 0.9197 | 0.0088 | 3.0000 | 347 | 112 | |
| 4 | 23 | 0.9231 | 0.0088 | 3.0000 | 348 | 112 | |
| 4 | 24 | 0.9264 | 0.0088 | 3.0000 | 349 | 112 | |
| 4 | 25 | 0.9298 | 0.0088 | 3.0000 | 350 | 112 | |
| 4 | 26 | 0.9331 | 0.0088 | 3.0000 | 351 | 112 | |
| 4 | 27 | 0.9365 | 0.0088 | 3.0000 | 352 | 112 |
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | quality_warning | 待验证 | 3 | 2026-07-23T18:08:45+00:00 |